Biosimilars, which at the most simplistic level can be thought of as a type of generic option for a biologic, offer an opportunity to help reduce total biologic drug spend.
Menu
Overview of the Biosimilar Landscape
- Published
- January 22, 2020
- - 4:06 pm
